INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

CRVOCervoMed Inc.

CIK 0001053691

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections4with evidence

CRVO · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BK
Blackburn KellyEVP, Clinical Development
CRVOCervoMed Inc.
Grant or award
A—
19.1K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Blackburn KellyEVP, Clinical Development · Oct 23, 2026
  • ← Insider ofevidence
    De Rosch MarkEVP, RA and GA and PgM · Oct 23, 2026
  • ← Insider ofevidence
    Winton MatthewChief Commercial and Business · Oct 23, 2026
9
DM
De Rosch MarkEVP, RA and GA and PgM
CRVOCervoMed Inc.
Grant or award
A
—
19.1K sh
Oct 22, 2026
Oct 23, 2026
traded Oct 22, 2026
+1d
SEC FORM 4

Evidence

9
WM
Winton MatthewChief Commercial and Business
CRVOCervoMed Inc.
Grant or award
A—
19.1K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence